Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?

Jangal M, Lebeau B, Witcher M.

Expert Opin Ther Targets. 2019 Jul;23(7):565-578. doi: 10.1080/14728222.2019.1627329. Epub 2019 Jun 10.

PMID:
31177918
2.

Oncogenic activity of poly (ADP-ribose) glycohydrolase.

Marques M, Jangal M, Wang LC, Kazanets A, da Silva SD, Zhao T, Lovato A, Yu H, Jie S, Del Rincon S, Mackey J, Damaraju S, Alaoui-Jamali M, Witcher M.

Oncogene. 2019 Mar;38(12):2177-2191. doi: 10.1038/s41388-018-0568-6. Epub 2018 Nov 20.

3.

Peroxisomes and cancer: The role of a metabolic specialist in a disease of aberrant metabolism.

Dahabieh MS, Di Pietro E, Jangal M, Goncalves C, Witcher M, Braverman NE, Del Rincón SV.

Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):103-121. doi: 10.1016/j.bbcan.2018.07.004. Epub 2018 Aug 6. Review.

PMID:
30012421
4.

Competition between translation initiation factor eIF5 and its mimic protein 5MP determines non-AUG initiation rate genome-wide.

Tang L, Morris J, Wan J, Moore C, Fujita Y, Gillaspie S, Aube E, Nanda J, Marques M, Jangal M, Anderson A, Cox C, Hiraishi H, Dong L, Saito H, Singh CR, Witcher M, Topisirovic I, Qian SB, Asano K.

Nucleic Acids Res. 2017 Nov 16;45(20):11941-11953. doi: 10.1093/nar/gkx808.

5.

CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair.

Hilmi K, Jangal M, Marques M, Zhao T, Saad A, Zhang C, Luo VM, Syme A, Rejon C, Yu Z, Krum A, Fabian MR, Richard S, Alaoui-Jamali M, Orthwein A, McCaffrey L, Witcher M.

Sci Adv. 2017 May 24;3(5):e1601898. doi: 10.1126/sciadv.1601898. eCollection 2017 May.

6.

Proximal and distal regulation of the HYAL1 gene cluster by the estrogen receptor α in breast cancer cells.

Edjekouane L, Benhadjeba S, Jangal M, Fleury H, Gévry N, Carmona E, Tremblay A.

Oncotarget. 2016 Nov 22;7(47):77276-77290. doi: 10.18632/oncotarget.12630.

7.

LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.

Bianco S, Jangal M, Garneau D, Gévry N.

Oncogene. 2015 Aug 20;34(34):4509-18. doi: 10.1038/onc.2014.382. Epub 2014 Dec 1.

PMID:
25435372
8.

The transcriptional co-repressor TLE3 suppresses basal signaling on a subset of estrogen receptor α target genes.

Jangal M, Couture JP, Bianco S, Magnani L, Mohammed H, Gévry N.

Nucleic Acids Res. 2014 Oct;42(18):11339-48. doi: 10.1093/nar/gku791. Epub 2014 Sep 15.

9.

LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells.

Bianco S, Brunelle M, Jangal M, Magnani L, Gévry N.

Cancer Res. 2014 Apr 1;74(7):2015-25. doi: 10.1158/0008-5472.CAN-13-2351. Epub 2014 Feb 11.

Supplemental Content

Loading ...
Support Center